Asociación Española de Vacunología

Bibliografía

20/12/2018
image_pdfimage_print
  1. Van Man N, Luan Le T, Trach DD, et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis. 2005; 92(Suppl 1):S127-32.
  2. Giordano S, Serra G, Dones P, et al. Acute pancreatitis in children and rotavirus infection. Description of a case and minireview. New Microbiol. 2013;36:97-101.
  3. Thompson MJ, Gowdie PJ, Kirkwood CD, et al. Rotavirus cerebellitis: new aspects to an old foe? Pediatr Neurol. 2012;46:48-50.
  4. Bharwani SS, Shaukat Q, Basak R. A 10-month-old with rotavirus gastroenteritis, seizures, anasarca and systemic inflammatory response syndrome and complete recovery. BMJ Case Rep. 2011;2011. pii: bcr0420114126.
  5. Nakano I, Taniguchi K, Ishibashi-Ueda H, et al. Sudden death from systemic rotavirus infection and detection of nonstructural rotavirus proteins. J Clin Microbiol. 2011;49:4382-5.
  6. Limbos MA, Lieberman JM. Disseminated intravascular coagulation associated with rotavirus gastroenteritis: report of two cases. Clin Infect Dis. 1996;22:834-6.
  7. Berzosa-López R, Moreno-Pérez D, Martínez-Antón J, Ramos-Fernández JM. Hemicerebelitis asociada a gastroenteritis por rotavirus. An Pediatr. 2012;76:241-3.
  8. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med. 2004;351:2417.
  9. Richardson S, Grimwood K, Gorrell R, et al. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet. 1998;351:1844.
  10. Álvarez J, Aristegui J, LópezBelmonte JL, et al. Economic and psychosocial impact of rotavirus infection in Spain: A literatura review. Vaccine. 32(2014) 3740-3751
  11. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009;136:1939.
  12. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med. 1991;325:252.
  13. Organización Mundial de la Salud. Inmunización, vacunas y productos biológicos. Rotavirus. Disponible en: http://www.who.int/immunization/diseases/rotavirus/es/
  14. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-72.
  15. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58:1.
  16. Cunliffe NA, Bresee JS, Hart CA. Rotavirus vaccines: development, current issues. J Infect. 2002;45:1-9.
  17. Vesikari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014. Pediatr Infect Dis J. 2015;34:635.
  18. De Vos B, Han HH, Bouckenooghe A, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J. 2009;28:261.
  19. European Medicines Agency. http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000639/WC500054789.pdf
  20. European Medicines Agency. http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000669/WC500054185.pdf
  21. Centers for Disease Control and Prevention Website: www.cdc.gov/rotavirus/vaccination.html
  22. Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;(11):CD008521.
  23. Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis. 2009;200(Suppl 1):S16-27.
  24. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11.
  25. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23.
  26. Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370:513.
  27. Glass RI, Parashar UD. Rotavirus vaccines-balancing intussusception risks and health benefits. N Engl J Med. 2014;370:568-70.
  28. La vacunación frente al rotavirus es segura en los prematuros hospitalizados AEP. CAV-AEP. 2018. Disponible en: http://vacunasaep.org/profesionales/noticias/vacuna-rotavirus-prematuros
  29. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8:642.


Subir al menú